Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-10-05

Clinical Trial Update: Safety and Effectiveness Study of a Non-Crosslinked HA Alkylamide HYADD(TM) 4 Hydrogel for Osteoarthritis of the Knee [NA]

View source ↗

Summary

Clinical Trial Update assessing safety and effectiveness of HYADD-4 Hydrogel (non-crosslinked hyaluronic acid alkylamide) for knee osteoarthritis. The current s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HYADD-4 Hydrogel (non-crosslinked hyaluronic acid alkylamide)

Snippet

Sponsor: Fidia Farmaceutici s.p.a. | Conditions: Knee Osteoarthritis | NA | Status: UNKNOWN